Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study

Journal of Psychiatry and Neuroscience

Volumn 37, Issue 3, 2012, Pages 185-192

  Hajek, Tomas ^a   Bauer, Michael ^b   Pfennig, Andrea ^b   Cullis, Jeffrey ^a   Ploch, Jana ^b   O'Donovan, Claire ^a   Bohner, Georg ^c   Klingebiel, Randolf ^c   Young, L Trevor ^d   Macqueen, Glenda M ^e   Alda, Martin ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DRUG EXPOSURE; FEMALE; GERMANY; HUMAN; HUMAN TISSUE; MALE; MULTICENTER STUDY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREFRONTAL CORTEX;

EID: 84860515845     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.110097     Document Type: Article

References (43)

1. Zarate CA, Singh J, Manji HK. Cellular plasticity cascades: Targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 2006;59:1006-1020.
2. Gould TD, Picchini AM, Einat H, et al. Targeting glycogen synthase kinase-3 in the CNS: Implications for the development of new treatments for mood disorders. Curr Drug Targets 2006;7:1399-1409.
3. Moore GJ, Bebchuk JM, Hasanat K, et al. Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000;48:1-8.
4. Moore GJ, Bebchuk JM, Wilds IB, et al. Lithium-induced increase in human brain grey matter. Lancet 2000;356:1241-1242.
5. Schuff N, Meyerhoff DJ, Mueller S, et al. N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease. Adv Exp Med Biol 2006;576:241-262.
6. Moffett JR, Namboodiri AM. Expression of N-acetylaspartate and N-acetylaspartylglutamate in the nervous system. Adv Exp Med Biol 2006;576:7-26.
7. Moffett JR, Ross B, Arun P, et al. N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89-131.
8. Brambilla P, Stanley JA, Sassi RB, et al. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004;29:1918-1924.
9. Friedman SD, Dager SR, Parow A, et al. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry 2004;56:340-348.
10. Davanzo P, Thomas MA, Yue K, et al. Decreased anterior cingulate myoinositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001; 24:359-369.
11. Dickstein DP, Towbin KE, van der Veen JW, et al. Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. J Child Adolesc Psychopharmacol 2009; 19: 61-73.
12. Patel NC, DelBello MP, Cecil KM, et al. Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium. J Child Adolesc Psychopharmacol 2008; 18: 132-139.
13. Silverstone PH, Wu RH, O'Donnell T, et al. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 2003;18:73-79.
14. Brambilla P, Stanley JA, Nicoletti MA, et al. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 2005;86:61-67.
15. Kato T, Hamakawa H, Shioiri T, et al. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996; 21: 248-254.
16. Amaral JA, Tamada RS, Issler CK, et al. A 1HMRS study of the anterior cingulate gyrus in euthymic bipolar patients. Hum Psycho pharmacol 2006;21:215-220.
17. Colla M, Schubert F, Bubner M, et al. Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol. Mol Psychiatry 2009; 14: 696-704, 647.
18. Gallelli KA, Wagner CM, Karchemskiy A, et al. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disord 2005;7:589-597.
19. Hajek T, Bernier D, Slaney C, et al. A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy. J Psychiatry Neurosci 2008;33:531-540.
20. Olvera RL, Caetano SC, Fonseca M, et al. Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J Child Adolesc Psychopharmacol 2007;17:461-473.
21. Caetano SC, Olvera RL, Hatch JP, et al. Lower N-acetyl-aspartate levels in prefrontal cortices in pediatric bipolar disorder: a (1)H magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry 2011;50:85-94.
22. Sassi RB, Stanley JA, Axelson D, et al. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry 2005;162:2109-2115.
23. Winsberg ME, Sachs N, Tate DL, et al. Decreased dorsolateral pre-frontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000; 47: 475-481.
24. Ohara K, Isoda H, Suzuki Y, et al. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Res 1998;84:55-60.
25. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) New York: Biometrics Research, New York State Psychi atric Institute; 2002.
26. Hamilton M. A rating scale for depression. J Neurol Psychiatry 1960;23:56-62.
27. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: Reliability, validity and sensitivity. B J Psychiatry 1978; 133:429-435.
28. Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP. Psychiatry Res 1997;73:159-171.
29. McLean MA, Woermann FG, Barker GJ, et al. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magn Reson Med 2000;44:401-411.
30. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260-264.
31. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
32. Kreiss R. Quantitation and quality assessment in clinical spectroscopy. International Society for Magnetic Resonance in Medicine, Twelfth Scientific Meeting; 2004 May 15-21; Kyoto, Japan.
33. Gruber S, Frey R, Mlynarik V, et al. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol 2003;38:403-408.
34. DelBello MP, Cecil KM, Adler CM, et al. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: A proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2006; 31:1264-1273.
35. Davanzo P, Yue K, Thomas MA, et al. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry 2003;160: 1442-1452.
36. Forester BP, Finn CT, Berlow YA, et al. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: A lithium-7 and proton magnetic res -onance spectroscopy study. Bipolar Disord 2008;10:691-700.
37. de Sousa RT, van de Bilt MT, Diniz BS, et al. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study. Neurosci Lett 2011;494:54-56.
38. Forlenza OV, Diniz BS, Radanovic M, et al. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: Randomised controlled trial. Br J Psychiatry 2011; 198: 351-356.
39. Cecil KM, DelBello MP, Morey R, et al. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 2002;4:357-365.
40. Blasi G, Bertolino A, Brudaglio F, et al. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: A proton magnetic resonance spectroscopic imaging study. Psychiatry Res 2004; 131:95-105.
41. Garcia M, Huppertz HJ, Ziyeh S, et al. Valproate-induced metabolic changes in patients with epilepsy: Assessment with H-MRS. Epilepsia 2009;50:486-492.
42. Sumitani S, Harada M, Kubo H, et al. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry Res 2007;154:85-92.
43. Atmaca M, Yildirim H, Ozdemir H, et al. Hippocampal 1H MRS in first-episode bipolar I patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1235-1239.